Advertisement

Organisation › Details
Oxford Biomedica (Group)
Oxford Biomedica (LSE:OXB) is an innovative leading viral vector specialist focused on delivering life changing therapies to patients. Oxford Biomedica plc and its subsidiaries (the Group) work across key viral vector delivery systems including those based on lentivirus, adeno-associated virus (AAV) and adenovirus, providing innovative solutions to cell and gene therapy biotechnology and biopharma companies for their process development, analytical development and manufacturing needs. Oxford Biomedica has built a sector leading lentiviral vector delivery system, LentiVector® platform, and is working on programmes from pre-clinical to commercial stage across a range of therapeutic areas with global partners. Oxford Biomedica is based across several locations and headquartered in Oxfordshire, UK. In 2022, the Group established Oxford Biomedica Solutions, a US based subsidiary AAV manufacturing and innovation business, based near Boston, US. *
![]() |
Start | 1996-01-01 splitoff |
Predecessor | University of Oxford | |
![]() |
Industry | gene therapy |
![]() |
Person | Mathias, Frank (Oxford Biomedica 202203– CEO before Rentschler + Medigene + Amgen GmbH + Servier DE + Hoechst) |
Person 2 | Doliveux, Roch (UCB 200602 CEO) | |
![]() |
Region | Oxford, Oxfordshire |
Country | United Kingdom (GB) | |
Street | Building 9400 Oxford Business Park | |
City | OX4 2HN Oxford, Oxfordshire | |
Tel | +44-1865-783000 | |
Address record changed: 2023-12-04 | ||
Basic data | Employees | E: 501 to 1,000 (2022-12-31) |
Currency | GBP | |
Annual sales | 139,989,000 (revenue, total, consolidated (2022) 2022-12-31) | |
Profit | -45,159,000 (2022-12-31) | |
Cash | 141,285,000 (2022-12-31) | |
* Document for »About Section«: Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford. | ||
Record changed: 2024-06-07 |
Advertisement

More documents for Oxford Biomedica (Group)
- [1] Oxford Biomedica plc. (7/17/24). "Press Release: Oxford Biomedica Announces Chief Financial Officer Transition. Lucinda Crabtree to Join as Chief Financial Officer". Basel....
- [2] Oxford Biomedica plc. (9/20/23). "Press Release: Oxford Biomedica and Institut Mérieux Enter into Exclusive Negotiations with Respect to the Proposed Acquisition by Oxford Biomedica of ABL Europe". Oxford....
- [3] Oxford Biomedica plc. (12/22/22). "Press Release: Oxford Biomedica to Present at 41st Annual J.P. Morgan Healthcare Conference". Oxford....
- [4] Oxford Biomedica plc. (12/14/22). "Press Release: Oxford Biomedica Solutions Forms New Partnerships with Three Biotechnology Companies". Oxford....
- [5] Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford....
- [6] Oxford Biomedica plc. (5/6/22). "Press Release: Oxford Biomedica Solutions Announces Novel Dual Plasmid Transfection System". Bedford, MA....
- [7] Oxford Biomedica plc. (3/11/22). "Press Release: Oxford Biomedica Broadens Its Viral Vector Capabilities with the Launch of Oxford Biomedica Solutions, a Full Scope AAV Business in Boston, Following Closing of Its Deal with Homology". Oxford....
- [8] Sio Gene Therapies Inc.. (1/31/22). "Press Release: Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO Transition". New York, NY & Durham, NC....
- [9] Oxford Biomedica plc. (1/28/22). "Press Release: Oxford Biomedica Broadens Leading Viral Vector Offerings by Incorporating Homology Medicines’ Established AAV Capabilities into a Newly Formed AAV Manufacturing and Innovation Business in the US with Homo...
- [10] Oxford Biomedica plc. (7/15/21). "Press Release: Oxford Biomedica Appoints Dr. Michael Hayden as Non-Executive Director". Oxford....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top